期刊文献+

慢性肾脏病不同时期血清CysC、β_2-MG的变化特点及其与Scr的相关性研究 被引量:5

Research on the Characteristic of the Change of Serum Cystatin C and Beta2-microglobulin Concentration in Different Stages of Chronic Kidney Disease and the Correlation with Serum Creatinine.
下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)不同时期血清胱抑素C(cystatin C,CysC)和β2-微球蛋白(β2-MG)的变化特点及其与血肌酐(Scr)的相关性。方法根据肾小球滤过率(GFR)将研究对象分为CKD 1、2、3、4、5期组,测定不同肾功能时期Cy-sC、β2-MG、Scr、尿素氮(BUN)水平,分别与CKD1期组比较并将各期CysC、β2-MG和Scr进行相关性分析。结果 CKD2、3、4、5期组cystatin C、β2-MG与CKD1组比较有统计学意义(P<0.01)。而CKD3、4、5期组SCr、BUN与CKD1组比较才有统计学意义(P<0.01)。相关分析显示,385例患者血清cystatin C与SCr之间呈正相关(r=0.85,P<0.01),β2-MG与SCr之间呈正相关(r=0.88,P<0.01);除CKD2期组SCr与cystatin C、β2-MG没有相关性外,其余各组SCr与cystatin C、β2-MG均有相关性。结论慢性肾脏病患者的血清cysattniC、β2-MG在CKD2期就明显升高,提示在轻度肾功能不全患者中,CysC、β2-MG的灵敏度要明显优于SCr;CysC、β2-MG比SCr能更及时、早期反映GFR的下降。 Objective To investigate the characteristic of the change of serum cystatin C and beta2 - microglobulin concentration in different stages of chronic kidney disease and to study the correlation with serum ereatinine. Methods According to glomerular filtration rate, patients were divided into five groups :1,2,3,4,5 stages of CKD groups. CysC,β2 - MG,Ser and BUN of 385 CKD patients were detected . Above mentioned chemical examination indexes of CKD 2,3,4,5 stages were compared with CKD1 respectively. CysC and β2 - MG of every CKD stage were processed by correlated analysis with Scr in accordingly CKD stages. Results The level of serum cystatin C and β2 - MG of CKD 2,3,4,5 stages had statistical significance compared to CKD1 stages( P 〈 0. 01 ) ,while the level of Scr and BUN of CKD 3,4,5 stages had statisticcal significance compared to CKD1 stages( P 〈 0. 01 ). The level of serum cystatin C was positively correlated with SCr (r = 0.85 ,P 〈 0. 01 )and the level of β2 -MG was also positively correlated with SCr (r = 0. 88 ,P 〈 0. 01 ). Except CKD2 stage, the/eve/of serum cystatin C and beta2 - microglobulin was positively correlated with SCr in other CKD stages. Conclusion Serum cystatin C and β2 -MG concentration of chronic kidney disease obviously increased in CKD2 stage,which indicated that the sensitivity of cystatin C and β2 - MG was better than serum creatinine and they could reflect the decrease of GFR earlier than serum creatinine in mild renal inadequacy patients.
出处 《医学研究杂志》 2011年第3期104-107,共4页 Journal of Medical Research
关键词 慢性肾脏病(CKD) CYSTATIN C Β2-微球蛋白 肾功能 CKD Cystatin C β2 - microglobulin Renal function
  • 相关文献

参考文献8

二级参考文献30

  • 1徐国宾,李志艳.应重视实验室检查在慢性肾病早期诊断中的应用[J].中华检验医学杂志,2006,29(11):961-965. 被引量:78
  • 2李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 3Newman DJ,Thakkar H, Robert G, et al. Serum Cystatin Cmeasured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatitine.Kidney Int,1995,47:312-318.
  • 4Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem, 1992,38 : 1933-1953.
  • 5Giovannetti S, Barsotti G. In defense of creatinine clearance.Nephron, 1991,59: 11-14.
  • 6Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med,1999,130:461-470.
  • 7Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol, 2000, 11 : A0828 (abstract).
  • 8Eknoyaa G, Levin N. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis,2001, 37 (1 Suppl 1):S5-S6. Erratum in: Am J KidneyDis, 2001,38:917.
  • 9Zuo L, Ma YC, Zhou YH, et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am .I Kidney Dis, 2005, 45:463-472.
  • 10Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance.J Nucl Med, 1996, 37:1883-1890.

共引文献816

同被引文献47

引证文献5

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部